nerolidol has been researched along with Leishmaniasis, Mucocutaneous in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cardoso, MDG; Ceole, LF; Soares, MJ | 1 |
1 other study(ies) available for nerolidol and Leishmaniasis, Mucocutaneous
| Article | Year |
|---|---|
Nerolidol, the main constituent of Piper aduncum essential oil, has anti-Leishmania braziliensis activity.
Topics: Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Oils, Volatile; Piper; Plant Oils; Sesquiterpenes; THP-1 Cells | 2017 |